[Recommendations for the medical treatment of rheumatoid arthritis]
Rev Invest Clin
.
2005 Sep-Oct;57(5):735-55.
[Article in Spanish]
Authors
Efrain Díaz-Jouanen
1
,
Carlos Abud-Mendoza
,
Mario Alberto Garza-Elizondo
,
Gabriel Medrano-Ramírez
,
J Javier Orozco-Alcalá
,
César Francisco Pacheco-Tena
,
Carlos Pineda-Villaseñor
,
Juan Carlos Pozos-Espíndola
,
Francisco Ramos-Niembro
,
Manuel Robles-San Román
,
Ernesto J Santana-Sahagún
Affiliation
1
Grupo de Estudio de Nuevas Terapias en Enfermedades reumáticas, Facultad de Medicina UNAM. monica.ledesma@abbott.com
PMID:
16419469
No abstract available
Publication types
Review
MeSH terms
Antirheumatic Agents
Arthritis, Rheumatoid / complications
Arthritis, Rheumatoid / drug therapy*
Decision Trees
Humans
Practice Guidelines as Topic
Prognosis
Risk Factors
Tuberculosis / complications
Substances
Antirheumatic Agents